| # | Title | Journal | Year | Citations |
|---|
| 1 | Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression | Nature Genetics | 2018 | 2,224 |
| 2 | Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis | Lancet, The | 2009 | 1,663 |
| 3 | Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) | Clinical Neurophysiology | 2014 | 1,647 |
| 4 | Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS) | Clinical Neurophysiology | 2017 | 1,213 |
| 5 | Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders | Nature Reviews Drug Discovery | 2010 | 774 |
| 6 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision | World Journal of Biological Psychiatry | 2008 | 661 |
| 7 | Development of the EURO–D scale – a European Union initiative to compare symptoms of depression in 14 European centres | British Journal of Psychiatry | 1999 | 612 |
| 8 | The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption | Nature Medicine | 2005 | 598 |
| 9 | Machine Learning Approaches for Clinical Psychology and Psychiatry | Annual Review of Clinical Psychology | 2018 | 520 |
| 10 | Prefrontal Transcranial Direct Current Stimulation Changes Connectivity of Resting-State Networks during fMRI | Journal of Neuroscience | 2011 | 501 |
| 11 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance | World Journal of Biological Psychiatry | 2012 | 498 |
| 12 | BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer’s Disease | PLoS ONE | 2013 | 412 |
| 13 | Use of Neuroanatomical Pattern Classification to Identify Subjects in At-Risk Mental States of Psychosis and Predict Disease Transition | Archives of General Psychiatry | 2009 | 382 |
| 14 | Accelerated Brain Aging in Schizophrenia and Beyond: A Neuroanatomical Marker of Psychiatric Disorders | Schizophrenia Bulletin | 2014 | 369 |
| 15 | Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial | British Journal of Psychiatry | 2010 | 364 |
| 16 | Association of the Brain-Derived Neurotrophic Factor Val66Met Polymorphism With Reduced Hippocampal Volumes in Major Depression | Archives of General Psychiatry | 2007 | 357 |
| 17 | Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci | Molecular Psychiatry | 2014 | 353 |
| 18 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects | World Journal of Biological Psychiatry | 2013 | 343 |
| 19 | Depression-Related Variation in Brain Morphology Over 3 Years | Archives of General Psychiatry | 2008 | 329 |
| 20 | Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care | International Journal of Psychiatry in Clinical Practice | 2012 | 327 |
| 21 | Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects | Science | 2009 | 299 |
| 22 | Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections | PLoS ONE | 2010 | 294 |
| 23 | Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial | World Psychiatry | 2015 | 293 |
| 24 | Prevention of Psychosis | JAMA Psychiatry | 2020 | 287 |
| 25 | Interaction of childhood stress with hippocampus and prefrontal cortex volume reduction in major depression | Journal of Psychiatric Research | 2010 | 275 |
| 26 | Aerobic Exercise Improves Cognitive Functioning in People With Schizophrenia: A Systematic Review and Meta-Analysis | Schizophrenia Bulletin | 2017 | 270 |
| 27 | Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies | Translational Psychiatry | 2017 | 268 |
| 28 | Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan | NeuroImage | 2020 | 260 |
| 29 | The Role of Immune System in Schizophrenia | Current Immunology Reviews | 2010 | 258 |
| 30 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia | World Journal of Biological Psychiatry | 2005 | 242 |
| 31 | Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture | PLoS Genetics | 2013 | 241 |
| 32 | Diagnostic neuroimaging across diseases | NeuroImage | 2012 | 240 |
| 33 | Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment | Schizophrenia Research | 2010 | 227 |
| 34 | The role of allopregnanolone in depression and anxiety | Progress in Neurobiology | 2014 | 227 |
| 35 | Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond | | 2011 | 217 |
| 36 | Genetics, Cognition, and Neurobiology of Schizotypal Personality: A Review of the Overlap with Schizophrenia | Frontiers in Psychiatry | 2014 | 208 |
| 37 | Common and distinct neural correlates of emotional processing in Bipolar Disorder and Major Depressive Disorder: A voxel-based meta-analysis of functional magnetic resonance imaging studies | European Neuropsychopharmacology | 2012 | 206 |
| 38 | Assessment and management of agitation in psychiatry: Expert consensus | World Journal of Biological Psychiatry | 2016 | 204 |
| 39 | Self-compassion as an emotion regulation strategy in major depressive disorder | Behaviour Research and Therapy | 2014 | 201 |
| 40 | ApoE attenuates unresolvable inflammation by complex formation with activated C1q | Nature Medicine | 2019 | 200 |
| 41 | Preventing progression to first-episode psychosis in early initial prodromal states | British Journal of Psychiatry | 2012 | 196 |
| 42 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia | World Journal of Biological Psychiatry | 2006 | 194 |
| 43 | MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide | Brain | 2020 | 183 |
| 44 | Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples | Molecular Psychiatry | 2006 | 180 |
| 45 | Transcranial direct current stimulation in treatment resistant depression: A randomized double-blind, placebo-controlled study | Brain Stimulation | 2012 | 174 |
| 46 | The promise of machine learning in predicting treatment outcomes in psychiatry | World Psychiatry | 2021 | 174 |
| 47 | Eating disorders in times of the COVID‐19 pandemic—Results from an online survey of patients with anorexia nervosa | International Journal of Eating Disorders | 2020 | 169 |
| 48 | Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis | American Journal of Psychiatry | 2016 | 167 |
| 49 | Structural correlates of psychopathological symptom dimensions in schizophrenia: A voxel-based morphometric study | NeuroImage | 2008 | 166 |
| 50 | Functional Connectivity Bias of the Orbitofrontal Cortex in Drug-Free Patients with Major Depression | Biological Psychiatry | 2010 | 164 |
